ADAGENE INC. - ADS EACH REPRESENTING 1.25 ORDINAR
1.4300
28-April-25 15:40:37
15 minutes delayed
Stocks
+0.0100
+0.70%
Today's range
1.4100 - 1.4500
ISIN
N/A
Source
NASDAQ
-
Adagene Appoints John Maraganore, Ph.D. as Executive Advisor
28 Apr 2025 08:00:00 By Nasdaq GlobeNewswire
-
23 Apr 2025 10:05:00 By Nasdaq GlobeNewswire
-
Adagene to Present at Stifel’s 2025 Virtual Targeted Oncology Forum
07 Apr 2025 08:00:01 By Nasdaq GlobeNewswire
-
Adagene Reports Full Year 2024 Financial Results and Provides Corporate Update
24 Mar 2025 08:00:00 By Nasdaq GlobeNewswire
-
Adagene to Present at 11th Annual Immuno-Oncology 360⁰ Summit
13 Mar 2025 08:00:00 By Nasdaq GlobeNewswire
-
Adagene to Present at Leerink’s Global Healthcare Conference 2025
06 Mar 2025 08:00:00 By Nasdaq GlobeNewswire
-
27 Feb 2025 08:00:01 By Nasdaq GlobeNewswire
-
27 Jan 2025 07:00:00 By Nasdaq GlobeNewswire
-
21 Jan 2025 17:00:00 By Nasdaq GlobeNewswire
-
14 Jan 2025 08:00:00 By Nasdaq GlobeNewswire
-
07 Nov 2024 10:01:00 By Nasdaq GlobeNewswire
-
09 Oct 2024 06:00:00 By Nasdaq GlobeNewswire
-
Adagene to Participate in Investor Conferences in September
29 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
Adagene Reports Six Month Financial Results for 2024 and Provides Corporate Update
25 Jul 2024 16:05:00 By Nasdaq GlobeNewswire
-
Adagene to Present at Investor Conferences in June
22 May 2024 16:45:00 By Nasdaq GlobeNewswire
-
Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
29 Mar 2024 09:00:00 By Nasdaq GlobeNewswire
-
Adagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory Board
07 Mar 2024 16:01:00 By Nasdaq GlobeNewswire
-
Adagene to Present at the Leerink Partners Global Biopharma Conference 2024
27 Feb 2024 08:00:01 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >